Investor Overview

Satsuma Pharmaceuticals Investor Relations

Corporate Presentation

Download

 

Recent News
Mar 10, 2020

SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today reported financial results for the...

Mar 5, 2020

South San Francisco, CA, March 5, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced the appointment of Rob Janosky to the newly...

Feb 18, 2020

South San Francisco, CA, February 18, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that John Kollins, President and Chief...

Stock Info
NASDAQSTSA